NASDAQ · Biotechnology

Applied Therapeutics, Inc. (APLT) Stock

$0.10 +0.00% NASDAQ: APLT Healthcare

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications.

Valuation

MetricValue
Price$0.10
Market Cap$14.86M
P/E Ratio-0.24
P/B Ratio-26.72
P/S Ratio14.86
EPS (TTM)$-0.76
52-Week High$1.50
52-Week Low$0.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-348.18%
ROA-180.79%
ROCE-173.33%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity-4.46
Current Ratio0.96

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$10.0M$0
Operating Profit$-94.0M$-106.0M$-83.0M$-65.0M$-104.0M
Net Profit$-94.0M$-106.0M$-83.0M$-120.0M$-106.0M
EPS$-4.28$-4.12$-2.18$-1.42$-0.76
Op Margin———-645.8%-22922.9%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$105.0M$90.0M$38.0M$55.0M$87.0M
Total Liabilities$23.0M$27.0M$34.0M$72.0M$30.0M
Cash$57.0M$54.0M$17.0M$50.0M$79.0M
Borrowings$3.0M$2.0M$2.0M$1.0M$3.0M

Latest News

Dollar at one-month low as cooling inflation offsets oil price risks Reuters · Jul 16, 2026 Post-stabilisation Announcement Business Wire · Jul 16, 2026 Meet the Dividend King Stock That Yields More Than Double the S&P 500 and Just Raised Its Dividend for the 64th Straight Year Motley Fool · Jul 16, 2026 Fujitsu and leading Japanese robotics companies to use Nvidia technology in 'physical AI' Associated Press · Jul 16, 2026 Lockheed Martin to Invest $100 Million in UK, Europe Defense Startups Through Venture Fund MT Newswires · Jul 16, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-78.0M$-91.0M$-78.0M$-55.0M$-84.0M
Investing Cash Flow$-19.0M$12.0M$13.0M$14.0M$0
Financing Cash Flow$3.0M$5.0M$3.0M$12.0M$9.0M
Net Cash Flow$39.0M$-4.0M$-37.0M$33.0M$30.0M
Free Cash Flow$-78.0M$-91.0M$-78.0M$-55.0M$-84.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.09
FCF Yield-453.33%
Quick Ratio0.96
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
CRDF $0.81 -2.98% -2.58 $53.22M 0.00%
ELTXElicio Therapeutics, Inc. $3.01 +0.17% -1.27 $57.29M 0.00%
FBRX $76.57 +0.08% -4.26 $1.57B 0.00%
MIST $1.13 -2.59% -2.00 $97.05M 0.00%

About Applied Therapeutics, Inc.

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is presently in a pediatric clinical study for the same indication in children. Additionally, AT-007 is being investigated for its potential to address sorbitol dehydrogenase deficiency and phosphomannomutase enzyme-CDG. Another key compound, AT-001, is currently undergoing pivotal Phase III clinical trials. This therapy is being evaluated for its efficacy in treating both diabetic cardiomyopathy and diabetic peripheral neuropathy. Beyond its clinical pipeline, the company also maintains an early-stage preclinical portfolio. This includes AT-003, which is being developed for diabetic retinopathy, and AT-104. AT-104 is a PI3K inhibitor specifically designed to target T-Cell Acute Lymphoblastic Leukemia, a rare form of blood cancer. Applied Therapeutics, Inc. was established in 2016 and operates from its headquarters in New York City.

Applied Therapeutics, Inc. is headquartered in US.

Applied Therapeutics, Inc. (APLT) stock trades at $0.10 with a market capitalization of $14.86M. The stock is valued at a price-to-earnings (P/E) ratio of -0.24, price-to-book of -26.72, price-to-sales of 14.86. Over the past 52 weeks the stock has ranged between $0.09 and $1.50, and currently trades 93.3% below its 52-week high.

On profitability, Applied Therapeutics, Inc. generates a return on equity (ROE) of -348.18%, return on capital employed of -173.33%.

Official website: www.appliedtherapeutics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides